Back to NBIX
ARMISTICE CAPITAL, LLC NBIX Position History
Neurocrine Biosciences, Inc. • Healthcare
Quarters held
6
Latest value
$70.9M
Q3 2026
Peak value
$116.3M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $97.8M |
| Q4 2025 | $116.3M |
| Q1 2026 | $95.4M |
| Q2 2026 | $90.3M |
| Q3 2026 | $80.2M |
| Q3 2026 | $70.9M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $70.9M | 500.0K | — | — |
| Q3 2026 | $80.2M | 565.3K | — | — |
| Q2 2026 | $90.3M | 535.8K | — | — |
| Q1 2026 | $95.4M | 724.0K | — | — |
| Q4 2025 | $116.3M | 820.2K | — | — |
| Q3 2025 | $97.8M | 697.0K | — | — |
Other funds holding NBIX
$1.3B
$1.3B
$1.2B
$1.2B
$1.1B
$1.1B
$997.5M
$992.8M